In vitro study on the schedule-dependency of the interaction between pemetrexed, gemcitabine and irradiation in non-small cell lung cancer and head and neck cancer cells-Reference-Cited by-同舟云学术

In vitro study on the schedule-dependency of the interaction between pemetrexed, gemcitabine and irradiation in non-small cell lung cancer and head and neck cancer cells

Published:2010-08-19 Issue:1 Volume:10 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Wouters An,Pauwels Bea,Lardon Filip,Pattyn Greet GO,Lambrechts Hilde AJ,Baay Marc,Meijnders Paul,Vermorken Jan B

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-10-441.pdf

Reference55 articles.

1. Seiwert TY, Salama JK, Vokes EE: The concurrent chemoradiation paradigm--general principles. Nat Clin Pract Oncol. 2007, 4: 86-100. 10.1038/ncponc0714.

2. Peters GJ, van der Wilt CL, Van Moorsel CJA, Kroep JR, Bergman AM, Ackland SP: Basis for effective combination cancer chemotherapy with antimetabolites. Pharmacol Ther. 2000, 87: 227-253. 10.1016/S0163-7258(00)00086-3.

3. Mackey JR, Mani RS, Selner M, Mowles D, Young JD, Belt JA, Crawford CR, Cass CE: Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res. 1998, 58: 4349-4357.

4. Huang P, Chubb S, Hertel LW, Grindey GB, Plunkett W: Action of 2',2'-difluorodeoxycytidine on DNA synthesis. Cancer Res. 1991, 51: 6110-6117.

5. Pauwels B, Korst A, Lardon F, Vermorken J: Combined modality therapy of gemcitabine and radiation. Oncologist. 2005, 10: 34-51. 10.1634/theoncologist.10-1-34.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective therapeutic benefit of X-rays and inhibitors of EGFR, PI3K/mTOR, and Bcl-2 in breast, lung, and cervical cancer cells;European Journal of Pharmacology;2021-12

2. High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma;Scientific Reports;2021-07-20

3. Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomas;BMJ Open Respiratory Research;2020-06

4. Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint Expression;International Journal of Molecular Sciences;2019-08-26

5. Therapeutic efficacy evaluation of radioimmunotherapy with 90 Y‐labeled anti‐podoplanin antibody NZ ‐12 for mesothelioma;Cancer Science;2019-03-12